Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
boston blog main
boston top stories
2
×
clinical trials
life sciences
mark timney
national blog main
national top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
aridis pharmaceuticals
aristea therapeutics
autoimmune diseases
axitinib
bellus health
biotech
biotech ipos
bolt biotherapeutics
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer
cell therapy
cholesterol
cidara therapeutics
cigna
concert pharmaceuticals
cvs health
What
drug
pricing
2
×
aces
advantages
announced
bar
big
bio
brings
ceo
cholesterol
expect
flexible
gamble
inclisiran
key
lowering
market
meant
medco
medco’s
medicine
medicines
mover
nasdaq
new
open
passed
patients
payers
physicians
plan
roundup
sets
taken
test
twice
type
ubiome
undone
Language
unset
Current search:
pricing
×
" boston top stories "
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing